drugset / Trial / NCT00506064

Melatonin Postoperative Sleep Study in Breast Cancer Patients

NCT00506064

Phase 1 Terminated 4 enrolled M.D. Anderson Cancer Center
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary Objective: To evaluate the impact of postoperative exogenous nocturnal melatonin supplementation on the early regulation of the sleep-wake cycle and its clinical impact (subjective improvement of the quality of sleep and reduction of cardiopulmonary events) during the first postoperative week following anesthesia and surgery in older breast cancer patients receiving a unilateral segmental mastectomy with or without intraoperative lymph node mapping, sentinel node biopsy and axillary node dissection. Secondary Objective: To collect data and validate the Postoperative Srejic Sleep SAT Survey Questionnaire (SAT implies relative subjective satisfaction of the patient's sleep in a scaled score out of 100 with 100 being the highest degree of satisfaction).

Timeline

Start
2004-02
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 0.15 mg/kg Oral

Indications